Skip to Main Content
About
Pipeline
Platform
Investors
Careers
Our Team
Partnering
News & Events
Contact Us
ABCL635
ABCL575
Targets and Modalities
Publications
Current Openings
Partnering
News & Events
Contact Us
Clinical Trials
Publications
Current Openings
About
Our Team
Partnering
News & Events
Contact Us
Pipeline
ABCL635
ABCL575
Platform
Targets and Modalities
Publications
Investors
Careers
Current Openings
604.559.9005
Get in touch
News & events.
Our news.
Filter by Category
Filter by Category
News
Event
Text Link
Filter by Year
Filter by Year
2025
2024
2023
2022
2021
2020
2019
2018
Link 1
Filter by Category
News
Event
Filter by Year
2025
2024
2023
2022
2021
2020
2019
2018
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Event
March 14, 2020
2020
SynBioBeta 2019
Read article
Event
March 14, 2020
2020
Discovery on Target 2020
Read article
News
March 12, 2020
2020
AbCellera and Lilly to Co-develop Antibody Therapies for the Treatment of COVID-19
Read article
News
March 10, 2020
2020
AbCellera Named to Fast Company's Annual List of the World's Most Innovative Companies for 2020
Read article
News
February 24, 2020
2020
Invetx Announces $15 million Series A Financing and Industry-leading Partnerships for Animal Biopharmaceutical Development
Read article
News
January 28, 2020
2020
AbCellera is mobilizing a response to the novel coronavirus outbreak as part of its DARPA P3 program
Read article
News
October 31, 2019
2019
Dr. Michael Hayden joins AbCellera's Board of Directors
Read article
News
September 27, 2019
2019
AbCellera named one of Canada's Top Growing Companies
Read article
News
September 5, 2019
2019
AbCellera Appoints Andrew Booth as Chief Financial Officer and Tryn Stimart as General Counsel
Read article
News
June 13, 2019
2019
AbCellera Announces Therapeutic Antibody Discovery Collaboration with Gilead in Infectious Disease
Read article
1